BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22574160)

  • 1. A novel solid-phase site-specific PEGylation enhances the in vitro and in vivo biostabilty of recombinant human keratinocyte growth factor 1.
    Huang Z; Zhu G; Sun C; Zhang J; Zhang Y; Zhang Y; Ye C; Wang X; Ilghari D; Li X
    PLoS One; 2012; 7(5):e36423. PubMed ID: 22574160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-phase N-terminus PEGylation of recombinant human fibroblast growth factor 2 on heparin-sepharose column.
    Huang Z; Ye C; Liu Z; Wang X; Chen H; Liu Y; Tang L; Zhao H; Wang J; Feng W; Li X
    Bioconjug Chem; 2012 Apr; 23(4):740-50. PubMed ID: 22433083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical modification of recombinant human keratinocyte growth factor 2 with polyethylene glycol improves biostability and reduces animal immunogenicity.
    Huang Z; Ni C; Chu Y; Wang S; Yang S; Wu X; Wang X; Li X; Feng W; Lin S
    J Biotechnol; 2009 Jul; 142(3-4):242-9. PubMed ID: 19477206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico enhancement of the stability and activity of keratinocyte growth factor.
    Poorebrahim M; Sadeghi S; Ghorbani R; Asghari M; Abazari MF; Kalhor H; Rahimi H
    J Theor Biol; 2017 Apr; 418():111-121. PubMed ID: 28093295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A better anti-diabetic recombinant human fibroblast growth factor 21 (rhFGF21) modified with polyethylene glycol.
    Huang Z; Wang H; Lu M; Sun C; Wu X; Tan Y; Ye C; Zhu G; Wang X; Cai L; Li X
    PLoS One; 2011; 6(6):e20669. PubMed ID: 21673953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratracheal instillation of keratinocyte growth factor decreases hyperoxia-induced mortality in rats.
    Panos RJ; Bak PM; Simonet WS; Rubin JS; Smith LJ
    J Clin Invest; 1995 Oct; 96(4):2026-33. PubMed ID: 7560096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of recombinant human keratinocyte growth factor on surfactant, plasma, and liver phospholipid homeostasis in hyperoxic neonatal rats.
    Raith M; Schaal K; Koslowski R; Fehrenbach H; Poets CF; Schleicher E; Bernhard W
    J Appl Physiol (1985); 2012 Apr; 112(8):1317-28. PubMed ID: 22323656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PEG chain length impacts yield of solid-phase protein PEGylation and efficiency of PEGylated protein separation by ion-exchange chromatography: insights of mechanistic models.
    Yoshimoto N; Isakari Y; Itoh D; Yamamoto S
    Biotechnol J; 2013 Jul; 8(7):801-10. PubMed ID: 23788446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of aerosol inhalation of recombinant human keratinocyte growth factor 2 on the lung tissue of rabbits with severe smoke inhalation injury].
    Fu ZH; Jiang ZY; Sun W; Xiong ZF; Liao XC; Liu MZ; Xu B; Guo GH
    Zhonghua Shao Shang Za Zhi; 2018 Jul; 34(7):466-475. PubMed ID: 30060349
    [No Abstract]   [Full Text] [Related]  

  • 10. rhKGF stimulates lung surfactant production in neonatal rats in vivo.
    Gesche J; Fehrenbach H; Koslowski R; Ohler FM; Pynn CJ; Griese M; Poets CF; Bernhard W
    Pediatr Pulmonol; 2011 Sep; 46(9):882-95. PubMed ID: 21462359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Producing functional recombinant human keratinocyte growth factor in Pichia pastoris and investigating its protective role against irradiation.
    Bahadori Z; Kalhor HR; Mowla SJ
    Enzyme Microb Technol; 2018 Apr; 111():12-20. PubMed ID: 29421032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-function engineering of interferon-beta-1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation.
    Basu A; Yang K; Wang M; Liu S; Chintala R; Palm T; Zhao H; Peng P; Wu D; Zhang Z; Hua J; Hsieh MC; Zhou J; Petti G; Li X; Janjua A; Mendez M; Liu J; Longley C; Zhang Z; Mehlig M; Borowski V; Viswanathan M; Filpula D
    Bioconjug Chem; 2006; 17(3):618-30. PubMed ID: 16704199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioactivity Determination of a Therapeutic Recombinant Human Keratinocyte Growth Factor by a Validated Cell-based Bioassay.
    Yao W; Guo Y; Qin X; Yu L; Shi X; Liu L; Zhou Y; Hu J; Rao C; Wang J
    Molecules; 2019 Feb; 24(4):. PubMed ID: 30769959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceleration of diabetic-wound healing with PEGylated rhaFGF in healing-impaired streptozocin diabetic rats.
    Huang Z; Lu M; Zhu G; Gao H; Xie L; Zhang X; Ye C; Wang Y; Sun C; Li X
    Wound Repair Regen; 2011; 19(5):633-44. PubMed ID: 22092801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico mutagenesis in recombinant human keratinocyte growth factor: Improvement of stability and activity in addition to decrement immunogenicity.
    Kalhor H; Sadeghi S; Marashiyan M; Enssi M; Kalhor R; Ganji M; Rahimi H
    J Mol Graph Model; 2020 Jun; 97():107551. PubMed ID: 32032931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the ion exchange chromatography for matrix-assisted PEGylation and purification of consensus interferon.
    Bajwa F; Ahmed N; Khan MA; Azam F; Akram M; Tahir S; Zafar AU
    Biotechnol Appl Biochem; 2020 Mar; 67(2):196-205. PubMed ID: 31589775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of interleukin-10 and recombinant human keratinocyte growth factor-2 on ventilation-induced lung injury in rats.
    Wu JY; Xiong ZH; Xiong GZ; Ding FQ; Lei J; Lu S; Li Y; He GM; Zhao LL; Liu ZJ
    Genet Mol Res; 2015 Dec; 14(4):15642-51. PubMed ID: 26634532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of heparin derivatives with recombinant human keratinocyte growth factor: Structural stability and bioactivity effect study.
    Kalhor H; Abolhasani H; Kalhor R; Komeili Movahhed T; Rahimi H
    Proteins; 2023 Apr; 91(4):542-554. PubMed ID: 36424813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratinocyte growth factor therapy in murine oleic acid-induced acute lung injury.
    Ulrich K; Stern M; Goddard ME; Williams J; Zhu J; Dewar A; Painter HA; Jeffery PK; Gill DR; Hyde SC; Geddes DM; Takata M; Alton EW
    Am J Physiol Lung Cell Mol Physiol; 2005 Jun; 288(6):L1179-92. PubMed ID: 15681392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase PEGylation of recombinant interferon alpha-2a for site-specific modification: process performance, characterization, and in vitro bioactivity.
    Lee BK; Kwon JS; Kim HJ; Yamamoto S; Lee EK
    Bioconjug Chem; 2007; 18(6):1728-34. PubMed ID: 17941681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.